"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Key data
Status
ActiveKRS number
0000092404REGON
01190140100000NIP/VAT code
5271113612VAT registration date
01/07/1996VAT status
ActiveBankruptcy proceedings
No proceedings"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
UL. KRAKOWIAKÓW 46, 02-255, WARSZAWA, POLSKASee on mapWebsite
-Incorporation date
18/02/2002Share capital
9,021,000.00 PLNPrimary activity
Research and experimental development on biotechnologyRepresentatives
5Representatives rights
DO REPREZENTACJI SPÓŁKI UPRAWNIONYCH JEST DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE LUB JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEMRepresentatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person | Title |
---|---|
A****** P**** P******** | Member of the management board |
L*** B* S**** | Member of the management board |
M****** R*******-H*** | Member of the management board |
T**** H***** | Member of the management board |
ANDRZEJ PAWEŁ POPKOWSKI | Member of the management board |
Persons with Significant Control
Financial ratios
Net Profit (zł)
9,660,912Financial report (Okredo)
Premium users: 1.00 credit
Indicator |
---|
Turnover (zł) |
Profit before tax (zł) |
Net Profit (zł) |
Working capital requirement (%) |
Liquidity ratio |
Net profitability (%) |
Equity (zł) |
Current liabilities (zł) |
Non current liabilities (zł) |
Non-current Assets (zł) |
2020 |
---|
169,069,440 |
11,177,889 |
11,883,821 |
0.20 |
1.93 |
7.03 |
31,818,377 |
36,945,964 |
0 |
- |
2021 |
---|
169,069,440 |
11,177,889 |
11,883,821 |
0.20 |
1.93 |
7.03 |
31,818,377 |
36,945,964 |
0 |
- |
2022 |
---|
234,179,491 |
13,752,485 |
9,660,912 |
0.20 |
2.01 |
4.13 |
41,479,289 |
46,390,928 |
0 |
- |
2022 |
---|
234,179,491 |
13,752,485 |
9,660,912 |
0.20 |
2.01 |
4.13 |
41,479,289 |
46,390,928 |
0 |
- |
2022
Turnover (zł)
234,179,491 zł39 % *
Profit before tax (zł)
13,752,485 zł23 % *
Net Profit (zł)
9,660,912 zł-19 % *
Working capital requirement (%)
0.20 0.00 % *
Liquidity ratio
2.01 4.15 % *
Net profitability (%)
4.13 %-41.25 % *
Equity (zł)
41,479,289 zł30 % *
Current liabilities (zł)
46,390,928 zł26 % *
Non current liabilities (zł)
0 zł- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
---|---|---|---|---|
- | - | - | - | - |
Documents
"NOVO NORDISK PHARMA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
---|---|
26/06/2024 | OD 01.01.2023 DO 31.12.2023 |
06/06/2023 | OD 01.01.2022 DO 31.12.2022 |
31/08/2022 | OD 01.01.2021 DO 31.12.2021 |
01/07/2021 | OD 01.01.2020 DO 31.12.2020 |
02/07/2020 | OD 01.01.2019 DO 31.12.2019 |